Moreover, it will be interesting to understand whether WNT6 may influence patient outcome by modulating the tumor microenvironment/immunologic landscape (Pai et al., 2017), or even by regulating the glioma stem cells population (Gonçalves et al., 2018), thus influencing tumor pathophysiology/recurrence and ultimately patient prognosis. Here, WNT6 is linked to central nervous system cancer.